Leo Pharma Inc recalls
1 recall filed under Leo Pharma Inc. The most recent was published March 4, 2026.
-
Class II · 8 months ago
Leo Pharma Inc Adbry, injection, 300 mg/2mL, Packaged as a) 1 x Single dose recall: Lack of Assurance of Sterility: due to the presence of particulate matter
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
About this page
Leo Pharma Inc appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.